Condition: Parkinson Disease · Sponsor: Insel Gruppe AG, University Hospital Bern
The investigators' objective is to improve L-dopa sensitive PD-related dysarthria and at the same time reduce DBS-induced speech disorders with the help of automated acoustic analysis in patients with STN-DBS-induced dysarthria.
This description comes directly from the study's public registry record.
Paul Krack, Prof. · 31 632 21 68 · paul.krack@insel.ch
Mario Sousa, MD · 31 664 23 49 · mario.sousa@insel.ch
Always discuss trial participation with your own doctor first.
| Czech Technical University Prague | Prague, Czechia | Active Not Recruiting |
| University Hospital Inselspital, Berne | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05182892